Phase III interlaboratory study of FETAX, Part 2: Interlaboratory validation of an exogenous metabolic activation system for Frog Embryo Teratogenesis Assay-Xenopus (FETAX)

Drug and Chemical Toxicology

Volumn 21, Issue 1, 1998, Pages 1-14

  Fort, Douglas J ^a,i   Stover, Enos L ^a   Bantle, John A ^b   Rayburn, James R ^b   Hull, Mendi A ^b   Finch, Robert A ^c   Burton, Dennis T ^d   Turley, Steven D ^d   Dawson, Douglas A ^e   Linder, Greg ^f   Buchwalter, David ^f   Dumont, James N ^g   Kumsher King, Marie ^h   Gaudet Hull, Angela M ^h  

^a Stover Group   (United States)

^b OKLAHOMA STATE UNIVERSITY   (United States)

^c US Army Ctr Environ Hlth Res   (United States)

^d UNIVERSITY OF MARYLAND   (United States)

^e ASHLAND UNIVERSITY   (United States)

^f ManTech Environ Research Laboratory   (United States)

^g OAK RIDGE NATIONAL LABORATORY   (United States)

^h SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

ⁱ NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYCLOPHOSPHAMIDE;

ANIMAL TISSUE; ARTICLE; BIOASSAY; CHEMICAL TERATOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; EMBRYOTOXICITY; LC 50; NONHUMAN; RELIABILITY; STANDARDIZATION; XENOPUS;

EID: 6844250763     PISSN: 01480545     EISSN: None     Source Type: Journal    
DOI: 10.3109/01480549809017846     Document Type: Article

References (37)

1. Dumont, J.N., Schultz, T W., Buchanan, M., and Kao, G. Frog Embryo Teratogenesis Assay: Xenopus (FETAX) - A Short-Term Assay Applicable to Complex Environmental Mixtures, Symposium on the Application of Short-Term Bioassays in the Analysis of Complex Environmental Mixtures III, M.D. Waters, S.S. Sanduh, J. Lewtas, L. Claxton, N. Chemoff, and S. Nesnow, Eds. New York, Plenum Press. (pp.) 393-405, 1983.
2. Fort, D.J., Dawson, D.A., and Bantle, J A. Development of A Metabolic Activation System for the Frog Embryo Teratogeneses Assay: Xenopus (FETAX). Teratogenesis, Carcinogenesis, Mutagenesis 8.251, 1988.
3. Fort, D J., Dawson, D.A., and Bantle, J.A., Evaluation of the Developmental Toxicity of Five Compounds with the Frog Embryo Teratogenesis Assay: Xenopus and a Metabolic Activation System. Journal of Applied Toxicology 9:377, 1989.
4. Fort, D.J., Rayburn, J.R., De Young, D.J., and Bantle, J.A. Assessing the Efficacy of an Aroclor 1254-Induced Exogenous Metabolic Activation System for FETAX. Drug and Chemical Toxicology 14:143, 1991.
5. Dawson, D.A., Fort, D.J., Smith, G.J., Newell, D.L., and Bantle, J.A. Evaluation of the Developmental Toxicity of Nicotine and Cotinine with Frog Embryo Teratogenesis Assay: Xenopus (FETAX) Teratogenesis, Carcinogenesis, Mutagenesis 8:329, 1988.
6. Fort, D J. and Bantle, J.A. Use of Frog Embryo Teratogenesis Assay -Xenopus (FETAX) to Evaluate the Developmental Toxicity of Diphenylhydantoin. Fundamental and Applied Toxicology 14:720, 1990.
7. Fort, D.J. and Bantle, J.A. Analysis of the Mechanism of Isoniazid-Induced Developmental Toxicity with Frog Embryo Teratogenesis Assay: Xenopus (FETAX). Teratogenesis, Carcinogenesis, Mutageness 10:463, 1990.
8. Fort, D.J., Rayburn, J R., and Bantle, J.A. Evaluation of Acetaminophen-Induced Developmental Toxicity using FETAX. Drug and Chemical Toxicology 15:329, 1992.
9. Fort, D.J., Stover, E.L., Rayburn, J.R., Hull, M., and Bantle, J.A. Evaluation of the Developmental Toxicity of Trichloroethylene and Detoxification Metabolites using Xenopus. Teratogenesis, Carcinogenesis, Mutagenesis 13:3, 1993.
10. Standard Guide for Conducting the Frog Embryo Teratogeneses Assay -Xenopus(FETAX); E 1439-91. American Society for Testing and Materials Annual Book of Standards. No. 1104, (pp.) 1119, 1991.
11. Bantle, J.A., Dumont, J N, Finch, R.A., Linder, G. Atlas of Abnormalities: A Guide for the Performance of FETAX. Oklahoma State Publications Department, Stillwater, OK. 1991.
12. Bantle, J.A., et al. Initial Interlaboratory Validation Study of FETAX: Phase I Testing. Journal of Applied Toxicology 14:213, 1994.
13. Bantle, J.A., et al. FETAX Interlaboratory Validation Study: Phase II Testing. Environmental Toxicology and Chemisty 13: 1629, 1994
14. Bantle, J.A., et al. FETAX Interlaboratory Validation Study: Phase III-Part 1 Testing. Journal of Applied Toxicology 16:517, 1995.
15. Freireich., E.J. Quantitative Comparison of Toxicity of Anti-Cancer Agents in Mouse Rat, Dog, Monkey and Man. Cancer Chemotherapy Report 50:219 1997.
16. Lucier, G., McDaniel, O., Brubaker, P., and Klein, R. Effects of Methylmercury Chloride on Rat Liver Microsomal Enzymes. Chemical Biological Interactions 4:265, 1971
17. Nash, T. The Colorimetric Estimation of Formaldehyde by Means of the Hantzsch Reaction. Biochemistry 55:412, 1955.
18. Bradford, M.M. A Rapid Sensitive Method for the Quanti-cation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Analytical Biochemistry 72:248, 1976
19. Dawson, D.A. and Bantle, J.A. Development of a Reconstituted Water Media and Preliminary Validation of the Frog Embryo Teratogeneses Assay: Xenopus (FETAX). Journal of Applied Toxicology 7:237, 1987.
20. Steel, R.G.D. and Torrie, J.H. Principles and Procedures of Statistics: A Biometrical Approach 2nd ed, McGraw-Hill, New York, 1990
21. Dawson, D.A., Bantle, J.A. Coadministration of Mehtylxanthines and Inhibitor Compounds Potentiates Teratogenicity in Xenopus Embryos. Teratology 35:221, 1987.
22. Kreybig Von, T. Die Teratogene Wirkung Cyclophosphamid Wahrend Der Embryonalen Entwicklungs-Phase Bei Der Ratte. Naunyn Schmiedeberg, Archives Pharmaxol 252:173, 1965.
23. Chaube, S., Kury, G., Murphy, M.L. Teratogenic Effects of Cyclophosphamide(NSC-26271) in the Rat. Cancer Chemotherapy Report 51:363, 1978.
24. Singh, S. The Teratogenicity of Cyclophosphamide (Endoran-Asta) in Rats. Indian Journal Medicine Research 59:1128, 1971.
25. Shogi, R., Ohzu, E. Effect of Endoxan on Developing Mouse Embryos. J. Fac Sc Hokkaido University (Ser VI) 15:662, 1965.
26. Gibson, J.E. Becker, B.A. The Teratogenicity of Cyclophosphamide in Mice. Cancer Research 28:475, 1968.
27. Fritz, H., Hess, R. Effects of Cyclophosphamide on the Embryonic Development of the Rabbit. Agents Actions 2:83, 1971.
28. McClure, H.M., Wilk, A.L., Horigan, E. A., Pratt, R.M. Induction of Craniofacial Malformations in Rhesus Monkeys (Macaca Mulatta) with Cyclophosphamide. Cleft Palate Journal 16:248, 1979.
29. Manson, J.M. and Smith, C.C. Influence of Cyclophosphamide and 4-Ketocyclophosphamide on Mouse Limb Development Teratology 15:291, 1977
30. Mirkes, F.E., Fantel, A.G., Greenway, J.C., and Shepard, T H. Teratogenicity of Cyclophosphamide Metabolites: Phosphoramide Mustard, Acrolein, and 4-Ketocyclophosphamide on Rat Embryos Cultured In Vitro. Toxicology and Applied Pharmacology 58:322, 1981.
31. Nishimura, H. and Nakai, K Congenital Malformations in Offspring Treated with Caffeine. Proceedings of the Society of Experimental Biology and Medicine 104:140, 1960.
32. Weathersbee, P.S. Olsen, L.K, and Lodge, H.R. Caffeine and Pregnancy. Postgraduate Medicine 62:64, 1977.
33. Borlee, I., Lechat, M.F., Bouchaert, A. and Misson, C. Coffee Risk Factor During Pregnancy? Louvain Medicine 97:279, 1978.
34. Heinonen, O.P, Slone, D. and Shapiro, S. Birth Defects and Drugs in Pregnancy. Publishing Science Group Incorporated, Littleton, Mass. 1977.
35. Linn, S., Schoenbaum, S. C., Menson, R.R., Rosner, B., Stabble-eld, P.G. and Ryan, K J. No Association Between Coffee Consumption and Adverse Outcomes of Pregnancy. New England Journal of Medicine 306:141, 1982.
36. Parkhurst, B.R., Warren-Hicks, W. and Noel, L.E. Performance Characteristics of Effluent Toxicity Tests. Summarization and Evaluation of Data Environmental Toxicology Chemistry 2:771, 1992.
37. Fort, D.J., Propst, T.L, Faulkner, B.C., Stover, E.L., Vollmuth, T., and Murray, F.J. Evaluation of the Developmental Toxicity of Caffeine and Caffeine Metabolites using Frog Embryo Teratogenesis Assay-Xenopus (FETAX), Food and Chemical Toxicology, in press.